Literature DB >> 9466285

Evans syndrome after autologous bone marrow transplant for recurrent Hodgkin's disease.

Y K Keung1, E Cobos, J Bolanos-Meade, S Issarachai, A Brideau, D Morgan.   

Abstract

The association of immune thrombocytopenic purpura (ITP) and autoimmune hemolytic anemia (AIHA) with Hodgkin's disease has been known for many years. Autoimmune cytopenia has also been described in patients that have undergone allogeneic or autologous bone marrow transplantation. We report a rare case of Evans syndrome in a patient 3 years after autologous bone marrow transplantation for recurrent Hodgkin's disease.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9466285     DOI： 10.1038/sj.bmt.1701017

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  5 in total

1.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.

Authors:  Paul A Carpenter; Carrie L Kitko; Sharon Elad; Mary E D Flowers; Juan C Gea-Banacloche; Jörg P Halter; Flora Hoodin; Laura Johnston; Anita Lawitschka; George B McDonald; Anthony W Opipari; Bipin N Savani; Kirk R Schultz; Sean R Smith; Karen L Syrjala; Nathaniel Treister; Georgia B Vogelsang; Kirsten M Williams; Steven Z Pavletic; Paul J Martin; Stephanie J Lee; Daniel R Couriel
Journal:  Biol Blood Marrow Transplant       Date:  2015-03-31       Impact factor: 5.742

Review 2.  Immune-Mediated Cytopenias After Hematopoietic Cell Transplantation: Pathophysiology, Clinical Manifestations, Diagnosis, and Treatment Strategies.

Authors:  Thomas F Michniacki; Christen L Ebens; Sung Won Choi
Journal:  Curr Oncol Rep       Date:  2019-08-15       Impact factor: 5.075

3.  A Case of Non-Hodgkin's Lymphoma in Patient with Coombs' Negative Hemolytic Anemia and Idiopathic Thrombocytopenic Purpura.

Authors:  So Yeon Park; Soyon Kim; Eun Sil Kim; Soon Uk Choi; Hee Jae Hyun; Ju Young Ahn; Ju Hyoung Lee; Seo Hee Ryu; Jae Hyun Park; Gyeong In Lee; Hyo Jin Lee
Journal:  Cancer Res Treat       Date:  2012-03-31       Impact factor: 4.679

4.  A Case of Evan's Syndrome Induced by Vedolizumab.

Authors:  Henry Jen; Bradley Morganstern; Lionel D'Souza
Journal:  ACG Case Rep J       Date:  2019-02-13

Review 5.  Evans syndrome: clinical perspectives, biological insights and treatment modalities.

Authors:  José Carlos Jaime-Pérez; Patrizia Elva Aguilar-Calderón; Lorena Salazar-Cavazos; David Gómez-Almaguer
Journal:  J Blood Med       Date:  2018-10-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.